Unknown

Dataset Information

0

Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation.


ABSTRACT: Positron emission tomography using [(18)F]fluorodeoxyglucose (FDG-PET) has emerged as the standard response assessment tool in frontline therapy for classical Hodgkin lymphoma (cHL). The ability of FDG-PET to predict outcomes in patients with relapsed cHL treated with modern standard salvage chemotherapy and autologous stem cell transplantation (ASCT) remains uncertain. Forty-six patients with relapsed/refractory cHL treated from 2001 to 2007 with standard salvage/ASCT therapy had FDG-PET available for blinded review. The results of pre-ASCT FDG-PET interpreted by the international harmonization project (IHP) criteria were compared with published prognostic models for prediction of event-free survival (EFS) and overall survival (OS). Overall, 3-year EFS was 62% and OS was 78%, with a median follow-up of 38 months. Pre-ASCT FDG-PET response significantly predicted 3-year EFS in FDG-PET-negative (82%) versus FDG-PET-positive (41%) patients (P = .02). A trend was observed for 3-year OS comparing FDG-PET-negative (91%) versus -positive (64%) patients (P = .08). Multivariate analysis demonstrated the independent prognostic significance of pre-ASCT FDG-PET for EFS with a hazard ratio (HR) of 3.2 (confidence interval [CI] 1.1-9.0, P = .03). Pre-ASCT FDG-PET scans predict EFS in patients with relapsed cHL patients treated with modern salvage/ASCT therapy and warrant prospective evaluation.

SUBMITTER: Smeltzer JP 

PROVIDER: S-EPMC3166401 | biostudies-other | 2011 Nov

REPOSITORIES: biostudies-other

altmetric image

Publications

Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation.

Smeltzer Jacob P JP   Cashen Amanda F AF   Zhang Qin Q   Homb Andrew A   Dehdashti Farrokh F   Abboud Camille N CN   Dipersio John F JF   Stockerl-Goldstein Keith E KE   Uy Geoffrey L GL   Vij Ravi R   Westervelt Peter P   Bartlett Nancy L NL   Fehniger Todd A TA  

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110503 11


Positron emission tomography using [(18)F]fluorodeoxyglucose (FDG-PET) has emerged as the standard response assessment tool in frontline therapy for classical Hodgkin lymphoma (cHL). The ability of FDG-PET to predict outcomes in patients with relapsed cHL treated with modern standard salvage chemotherapy and autologous stem cell transplantation (ASCT) remains uncertain. Forty-six patients with relapsed/refractory cHL treated from 2001 to 2007 with standard salvage/ASCT therapy had FDG-PET availa  ...[more]

Similar Datasets

| S-EPMC6960479 | biostudies-literature
| S-EPMC8297052 | biostudies-literature
| S-EPMC10651466 | biostudies-literature
| S-EPMC8212249 | biostudies-literature
| S-EPMC7601361 | biostudies-literature
| S-EPMC9344040 | biostudies-literature
| S-EPMC6536701 | biostudies-literature
| S-EPMC5948762 | biostudies-literature
| S-EPMC8215529 | biostudies-literature